1-Oxa-6-azaspiro[2,5]octane-6-carboxylic acid tert-butyl ester, 95.0%, 1g

1-Bromo-2-(2-bromoethyl)benzene, 95.0%, 100mg

3-MORPHOLINOPHENOL, 95.0%, 5g

1H,1'H-2,2'-Bipyrrole, 97.0%, 50mg

2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid, 95.0%, 250mg

Ethyl (4-Bromobenzoyl)acetate>98.0%(GC)5g

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 1.00 µm, 1 Piece(s)

(1R,3S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid, 95.0%, 5g

(2E)-1-(2,5-dimethoxyphenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide, 98.00%, 50mg

2-Bromo-5-chloro-3-methylpyrazine, 95.0%, 100mg

4-FLUORO-2-IODOBENZYL ALCOHOL, 95.0%, 5g

3-[(2-chloro-6-fluorobenzyl)oxy]-4-methoxybenzaldehyde, 95.0%, 1g